Skip to Main content Skip to Navigation
Journal articles

Linking LOXL2 to Cardiac Interstitial Fibrosis

Abstract : Cardiovascular diseases (CVDs) are the leading causes of death worldwide. CVD pathophysiology is often characterized by increased stiffening of the heart muscle due to fibrosis, thus resulting in diminished cardiac function. Fibrosis can be caused by increased oxidative stress and inflammation, which is strongly linked to lifestyle and environmental factors such as diet, smoking, hyperglycemia, and hypertension. These factors can affect gene expression through epigenetic modifications. Lysyl oxidase like 2 (LOXL2) is responsible for collagen and elastin cross-linking in the heart, and its dysregulation has been pathologically associated with increased fibrosis. Additionally, studies have shown that, LOXL2 expression can be regulated by DNA methylation and histone modification. However, there is a paucity of data on LOXL2 regulation and its role in CVD. As such, this review aims to gain insight into the mechanisms by which LOXL2 is regulated in physiological conditions, as well as determine the downstream effectors responsible for CVD development.
Document type :
Journal articles
Complete list of metadata
Contributor : laboratoire CarMeN Connect in order to contact the contributor
Submitted on : Wednesday, May 26, 2021 - 3:05:14 PM
Last modification on : Thursday, September 1, 2022 - 3:59:20 AM
Long-term archiving on: : Friday, August 27, 2021 - 7:59:46 PM


Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution 4.0 International License



M. Erasmus, E. Samodien, S. Lecour, M. Cour, O. Lorenzo, et al.. Linking LOXL2 to Cardiac Interstitial Fibrosis. International Journal of Molecular Sciences, MDPI, 2020, 21 (16), pp.5913. ⟨10.3390/ijms21165913⟩. ⟨inserm-03237049⟩



Record views


Files downloads